Applikon Biotechnology is a world leader in developing advanced bioreactor systems from laboratory scale to production scale.
Applikon Biotechnology is a world leader in developing advanced bioreactor systems from laboratory scale to production scale.
AM-Pharma is a biopharma company developing a proprietary recombinant human Alkaline Phosphatase (recAP) against Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia.
ProFibrix is a biotech company specialized in fibrinogen technology to develop innovative products for the hemostasis and regenerative medicine markets.
Taconic Biosciences is a leading provider of research models with a wide range of Taconic Transgenic Models (TTM).
PamGene is a biotech company specialized in kinase and nuclear receptor assays for personalized medicine and drug discovery.
Calypso Biotech is a biotech company developing antibody therapies up to clinical proof-of-concept by leveraging its expertise in immunology and drug development. Calypso Biotech’s portfolio consists of two therapeutic antibody programs planned to reach the clinic by 2016-2017 against gastro-intestinal auto-immune syndromes such as Crohn’s and Refractory Celiac diseases.
Synaptic Systems (SySy) is a biotech company providing tailor-made antibodies for neuroscientist and cellbiologist.
Second Genome is a biotech company developing product candidates that modulate microbe-host and microbe-microbe interactions across multiple disease areas.
ExpreS2ion Biotechnologies is a world leading contract research organization (CRO) for the production in Drosophila Schneider-2 (S2) cells using its proprietary and complete S2 recombinant protein technology ExpreS2.
ToolGen is a biotech company editing the genetic information in microbial, plant, animal, and human cells. ToolGen aims to translate the potential of its innovative platform technology into transformative products for biomedicine and agriculture.